Work

Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial)

Year: 2024

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-24-2461

Authors: Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, Matthias M. Weber

Institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, University Hospital in Halle, Martin Luther University Halle-Wittenberg, Philipps University of Marburg, Universitätsklinikum Gießen und Marburg

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405922540

FWCI: 2.856

Cites: 28

Cited by: 11

Related to: 10